SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.07.15 | Novartis buy | Citigroup Corp. | |
| 13.07.15 | Novartis buy | Jefferies & Company Inc. | |
| 13.07.15 | Roche buy | Jefferies & Company Inc. | |
| 10.07.15 | Novartis buy | UBS AG | |
| 09.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 08.07.15 | Roche overweight | JP Morgan Chase & Co. | |
| 07.07.15 | Novartis buy | UBS AG | |
| 06.07.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 03.07.15 | Novartis buy | Citigroup Corp. | |
| 01.07.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.07.15 | Roche buy | Deutsche Bank AG | |
| 01.07.15 | Novartis neutral | Independent Research GmbH | |
| 01.07.15 | Roche buy | HSBC | |
| 30.06.15 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.06.15 | Roche overweight | JP Morgan Chase & Co. | |
| 26.06.15 | Roche buy | HSBC | |
| 26.06.15 | Novartis buy | HSBC | |
| 24.06.15 | Roche overweight | JP Morgan Chase & Co. | |
| 23.06.15 | Novartis buy | Citigroup Corp. | |
| 19.06.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 16.06.15 | Novartis buy | UBS AG | |
| 05.06.15 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 05.06.15 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 04.06.15 | Novartis buy | Citigroup Corp. | |
| 02.06.15 | Roche overweight | JP Morgan Chase & Co. | |
| 02.06.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 22.05.15 | Roche buy | UBS AG | |
| 21.05.15 | Novartis buy | Jefferies & Company Inc. | |
| 21.05.15 | Roche buy | Jefferies & Company Inc. | |
| 21.05.15 | Novartis buy | Citigroup Corp. | |
| 21.05.15 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.05.15 | Roche buy | UBS AG | |
| 15.05.15 | Roche buy | Goldman Sachs Group Inc. | |
| 14.05.15 | Roche overweight | JP Morgan Chase & Co. | |
| 13.05.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.05.15 | Novartis buy | Citigroup Corp. | |
| 29.04.15 | Roche buy | Merrill Lynch & Co., Inc. | |
| 29.04.15 | Roche overweight | JP Morgan Chase & Co. | |
| 29.04.15 | Novartis buy | Citigroup Corp. | |
| 29.04.15 | Roche Neutral | Citigroup Corp. |